(Q35202301)

7 August 2017

title

D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging (English)

1 reference

7 August 2017

1 reference

Pingkun Yan

13

0 references

Paul H Chung

Paul H Chung

3

0 references

Bradford J. Wood

Bradford J Wood

16

0 references

Baris Turkbey

8

Baris Turkbey

1 reference

7 August 2017

17

Peter A Pinto

1 reference

7 August 2017

15

Peter L Choyke

1 reference

7 August 2017

9

Joanna Shih

1 reference

7 August 2017

Ardeshir R Rastinehad

1

Ardeshir R Rastinehad

1 reference

7 August 2017

5

Jochen Kruecker

1 reference

7 August 2017

11

W Marston Linehan

1 reference

7 August 2017

7

Julia K Locklin

1 reference

7 August 2017

2

Angelo A Baccala

1 reference

7 August 2017

10

Gennady Bratslavsky

1 reference

7 August 2017

12

Neil D Glossop

1 reference

7 August 2017

14

Samuel Kadoury

1 reference

7 August 2017

Juan M Proano

4

1 reference

7 August 2017

Sheng Xu

6

1 reference

7 August 2017

language of work or name

English

0 references

publication date

15 January 2011

1 reference

7 August 2017

1 reference

7 August 2017

volume

185

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

815-820

1 reference

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

13 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Imaging localized prostate cancer: current approaches and new developments.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

MR-guided biopsy of the prostate: an overview of techniques and a systematic review

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Prostate cancer: local staging at 3-T endorectal MR imaging--early experience

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Design of a novel MRI compatible manipulator for image guided prostate interventions

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Extended sector biopsy for detection of carcinoma of the prostate

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169005

Transrectal biopsy of the prostate

26 September 2018

1 reference

12 December 2020

Closed-loop control in fused MR-TRUS image-guided prostate biopsy

1 reference

12 December 2020

Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications

1 reference

12 December 2020

Prostatic needle biopsy

1 reference

12 December 2020

Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer

1 reference

12 December 2020

Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study

1 reference

12 December 2020

10.1016/J.JURO.2010.10.076

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference